This page is for healthcare professionals and other relevant decision makers in the UK. Information on this page is aligned to the Great Britain and Northern Ireland Summary of Product Characteristics.
Information about adverse event reporting can be found towards the bottom of the page.
Menu
Close
Menu
Close
Prescribing Information for COMIRNATY® JN.1▼ (bretovameran) for Great Britain and Northern Ireland and prescribing information for COMIRNATY® XBB.1.5▼ (raxtozinameran) for Great Britain is available here and at the bottom of the page. Adverse event reporting information can be found at the bottom of the page.
Check back soon to see if new videos have been added, or try looking for another brand or therapy area.
Adverse Event Reporting
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions via a Yellow card. Reporting forms and information can be found at https://coronavirus-yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.
Alternatively, adverse events of concern in association with COMIRNATY can be reported to Pfizer Medical Information on 01304 616161 or via www.pfizersafetyreporting.com.
Please do not report the same adverse event(s) to both systems as all reports will be shared between Pfizer and MHRA (in an anonymised form) and dual reporting will create unnecessary duplicates.
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
Marketing Authorisation
Holder: BioNTech
Manufacturing GmbH
COMIRNATY JN.1 COVID-19 mRNA Vaccine, which is based on BioNTech proprietary mRNA technology, was developed by both BioNTech and Pfizer.
The product information provided in this site is intended only for Healthcare Professionals and Other Relevant Decision Makers resident in the United Kingdom.
This website is brought to you by Pfizer Limited, a company registered in England and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent CT13 9NJ.
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
PP-CMR-GBR-0696. October 2024
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024